Boehringer Ingelheim Press Releases

Boehringer Ingelheim extends "one stop shop" service with new fill and finish capabilities

New data confirm superior blood pressure reductions in diabetic patients treated with TWYNSTA® compared to amlodipine alone

Boehringer Ingelheim and Zealand Pharma enter into a licence and collaboration agreement to advance novel compounds to treat Type-2 diabetes and obesity

Boehringer Ingelheim/Pfizer position regarding the recent publication by Singh et. al., in British Medical Journal, June 15, 2011

Actress Jane Seymour's appeal generates over one million votes to help prevent atrial fibrillation-related strokes

Metacam® now on the FEI "List of Detection Times"

FDA approves linagliptin tablets for the treatment of type 2 diabetes

Dabigatran etexilate recommended for approval in atrial fibrillation for stroke prevention in Europe

Boehringer Ingelheim maintains sales level/course set for the future: product pipeline well-filled

Breakthrough therapy dabigatran provides consistent benefit across all atrial fibrillation types and stroke risk groups

Boehringer Ingelheim’s lead hepatitis C compound moves into phase III – the first within the BI HCV portfolio

Sustained viral response achieved in 83% of hepatitis C infected patients with new HCV protease inhibitor from Boehringer Ingelheim

U.S. FDA approves once-daily Viramune® XR™ tablet for use in combination with other antiretroviral agents for treatment of HIV-1 infection in adults

Boehringer Ingelheim finalizes acquisition of AMGEN’s Fremont facility in the USA

Dabigatran etexilate is cost-effective for stroke prevention in atrial fibrillation, particularly in real-world clinical practice

The POET-COPD® study results demonstrate superiority of Spiriva® (tiotropium) over long-acting beta agonist salmeterol in reducing the risk for COPD exacerbations

Survey of people with atrial fibrillation and their doctors uncovers need for more education about the link between AF and stroke

Actress Jane Seymour takes up the fight against common heart rhythm disorder, atrial fibrillation and its link to stroke